561 related articles for article (PubMed ID: 18512190)
21. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.
Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400
[TBL] [Abstract][Full Text] [Related]
22. Intraindividual variability of striatal (1)H-MRS brain metabolite measurements at 3 T.
Soreni N; Noseworthy MD; Cormier T; Oakden WK; Bells S; Schachar R
Magn Reson Imaging; 2006 Feb; 24(2):187-94. PubMed ID: 16455408
[TBL] [Abstract][Full Text] [Related]
23. Two-voxel localization sequence for in vivo two-dimensional homonuclear correlation spectroscopy.
Delmas F; Beloeil JC; van der Sanden BP; Nicolay K; Gillet B
J Magn Reson; 2001 Mar; 149(1):119-25. PubMed ID: 11273760
[TBL] [Abstract][Full Text] [Related]
24. [Shortening of the measurement time by 1H-MR turbo spectroscopic imaging of the brain].
Träber F; Block W; Lamerichs R; Keller E; Schild HH
Rofo; 1997 Mar; 166(3):221-9. PubMed ID: 9156593
[TBL] [Abstract][Full Text] [Related]
25. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
[TBL] [Abstract][Full Text] [Related]
26. Detection of hidden metabolites by localized proton magnetic resonance spectroscopy in vivo.
Weber OM; Trabesinger AH; Duc CO; Meier D; Boesiger P
Technol Health Care; 1997 Dec; 5(6):471-91. PubMed ID: 9696165
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.
Lin K; Carrete H; Lin J; Peruchi MM; de Araújo Filho GM; Guaranha MS; Guilhoto LM; Sakamoto AC; Yacubian EM
Epilepsia; 2009 May; 50(5):1191-200. PubMed ID: 19220412
[TBL] [Abstract][Full Text] [Related]
28. Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla.
Jensen JE; Licata SC; Ongür D; Friedman SD; Prescot AP; Henry ME; Renshaw PF
NMR Biomed; 2009 Aug; 22(7):762-9. PubMed ID: 19388001
[TBL] [Abstract][Full Text] [Related]
29. Human brain MR spectroscopy thermometry using metabolite aqueous-solution calibrations.
Covaciu L; Rubertsson S; Ortiz-Nieto F; Ahlström H; Weis J
J Magn Reson Imaging; 2010 Apr; 31(4):807-14. PubMed ID: 20373423
[TBL] [Abstract][Full Text] [Related]
30. In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T.
Blüml S
J Magn Reson; 1999 Feb; 136(2):219-25. PubMed ID: 9986765
[TBL] [Abstract][Full Text] [Related]
31. Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility.
Geurts JJ; Barkhof F; Castelijns JA; Uitdehaag BM; Polman CH; Pouwels PJ
J Magn Reson Imaging; 2004 Sep; 20(3):366-71. PubMed ID: 15332241
[TBL] [Abstract][Full Text] [Related]
32. Vitamin C estimation with standard (1)H spectroscopy using a clinical 3T MR system: detectability and reliability within the human brain.
Shih YY; Büchert M; Chung HW; Hennig J; von Elverfeldt D
J Magn Reson Imaging; 2008 Aug; 28(2):351-8. PubMed ID: 18666156
[TBL] [Abstract][Full Text] [Related]
33. Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter.
Degaonkar MN; Pomper MG; Barker PB
J Magn Reson Imaging; 2005 Aug; 22(2):175-9. PubMed ID: 16028259
[TBL] [Abstract][Full Text] [Related]
34. Field strength dependence of PRESS timings for simultaneous detection of glutamate and glutamine from 1.5 to 7T.
Snyder J; Wilman A
J Magn Reson; 2010 Mar; 203(1):66-72. PubMed ID: 20031459
[TBL] [Abstract][Full Text] [Related]
35. Intramyocellular lipid quantification from 1H long echo time spectra at 1.5 and 3 T by means of the LCModel technique.
Skoch A; Jírů F; Dezortová M; Krusinová E; Kratochvílová S; Pelikánová T; Grodd W; Hájek M
J Magn Reson Imaging; 2006 May; 23(5):728-35. PubMed ID: 16568428
[TBL] [Abstract][Full Text] [Related]
36. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].
Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ
Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381
[TBL] [Abstract][Full Text] [Related]
37. Reduced brain glutamate in patients with Parkinson's disease.
Griffith HR; Okonkwo OC; O'Brien T; Hollander JA
NMR Biomed; 2008 May; 21(4):381-7. PubMed ID: 17907264
[TBL] [Abstract][Full Text] [Related]
38. In vivo brain (31)P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels.
Jensen JE; Drost DJ; Menon RS; Williamson PC
NMR Biomed; 2002 Aug; 15(5):338-47. PubMed ID: 12203225
[TBL] [Abstract][Full Text] [Related]
39. Effect of signal-to-noise ratio and spectral linewidth on metabolite quantification at 4 T.
Bartha R
NMR Biomed; 2007 Aug; 20(5):512-21. PubMed ID: 17205487
[TBL] [Abstract][Full Text] [Related]
40. In vivo magnetic resonance spectroscopy detection of combined glutamate-glutamine in healthy upper cervical cord at 3 T.
Solanky BS; Abdel-Aziz K; Yiannakas MC; Berry AM; Ciccarelli O; Wheeler-Kingshott CA
NMR Biomed; 2013 Mar; 26(3):357-66. PubMed ID: 23281170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
